Related Experiment Video
Updated: Aug 6, 2026

Ginger Moxibustion, A Non-pharmacological Treatment, for Diarrhea in Patients with Chronic Obstructive Pulmonary Disease
Published on: December 27, 2024
Ayurvedic management of Irritable Bowel Syndrome (Grahani Roga): A case report
Mayuri M Mungale1, Ashish A Thatere1
1Department of Kayachikitsa, Government Ayurved College and Hospital, Nagpur, India.
Abstract:
Irritable Bowel Syndrome (IBS) is a functional gastrointestinal disorder characterised by irregular bowel movements and abdominal discomfort in the absence of detectable structural abnormalities. This condition significantly affects both physical and mental health. Although the precise etiology remains unclear, factors such as abnormal gut motility and sensory function, central nervous system disturbances, psychological stress, and luminal changes are implicated. IBS affects approximately 10-15% of the population, yet only 10% of those affected seek medical care. The prevalence is highest between ages 15 and 50, ranging from 3% to 22%, with young women more frequently affected than men. Conventional management primarily involves dietary modification, pharmacotherapy, and stress reduction, but these approaches rarely provide complete relief. Evidence indicates increased mortality risks associated with antibiotics and antispasmodics, highlighting the need for adjunctive therapeutic strategies. In Ayurveda, IBS is analogous to Grahani Roga, which is characterised by Muhurbaddha-muhurdrava Mala Pravritti (alternate formed and loose stools), Udara Shoola (colicky abdominal pain), Adhmana (abdominal distention), and Dourbalya (weakness). This report presents a 71-year-old female with frequent evacuation of stools of varying consistency (4-5 times daily), abdominal pain, bloating, generalised weakness, and reduced sleep for three years. The diagnosis of Grahani Roga was established based on clinical features, and the Rome IV criteria confirmed IBS with predominant diarrhea. The patient experienced minimal relief from three years of conventional therapy. She subsequently received Piccha Basti (enema) for 16 days and Shamana (pacifying) medicine for four months. Improvements were observed on the IBS-GAI, IBS-SSS, IBS-AR, and IBS-QoL scales, suggesting the potential benefit of Ayurvedic interventions in the management of IBS.
Related Concept Videos
Irritable Bowel Syndrome III: Medical and Nursing Management
Irritable Bowel Syndrome
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
